Deallus latest news

The latest news from Deallus pharmaceutical and life science industry experts

The Migraine unveiling: Bringing the invisible disability to light

2024-09-26T10:41:27+01:00News|

Globally, headache disorders affected approximately 40% of the population, or 3.1 billion people in 2021. A migraine attack goes beyond a severe headache; it is a constellation of symptoms that may include neck pain, nausea, dizziness, visual disturbances and sensitivity to light, sounds and smell among a variety of other manifestations.

World Brain Day 2024

2024-07-19T09:21:45+01:00News|

Established by the World Federation of Neurology in 2014, World Brain Day seeks to raise public awareness on various neurological health topics each year. This year’s theme, “Brain Health and Prevention”, brings awareness to preventive measures that can alleviate the burden of many neurological conditions for patients across the world.

Revolutionizing Blood Cancer Treatment: A Dive into Cutting-Edge Therapies

2024-05-28T09:30:54+01:00News|

World Blood Cancer Day [28 May 2024] serves as a stark reminder of the significant challenges faced by the millions battling these life-threatening diseases. Here at Deallus, we have been privileged enough to partner with many leading companies in this space to support the development of lifechanging therapies across haemato-oncology.

Go to Top